4.6 Review

Therapeutic targets in liver fibrosis

Related references

Note: Only part of the references are listed.
Article Gastroenterology & Hepatology

Macrophage-mediated phagocytosis of apoptotic cholangiocytes contributes to reversal of experimental biliary fibrosis

Yury Popov et al.

AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2010)

Article Gastroenterology & Hepatology

Farglitazar Lacks Antifibrotic Activity in Patients With Chronic Hepatitis C Infection

John McHutchison et al.

GASTROENTEROLOGY (2010)

Article Gastroenterology & Hepatology

OPINION Antifibrotic therapies-emerging biomarkers as treatment end points

Jayant A. Talwalkar

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2010)

Article Medicine, General & Internal

Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis.

Arun J. Sanyal et al.

NEW ENGLAND JOURNAL OF MEDICINE (2010)

Article Gastroenterology & Hepatology

Effects of losartan on hepatic expression of nonphagocytic NADPH oxidase and fibrogenic genes in patients with chronic hepatitis C

Jordi Colmenero et al.

AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2009)

Article Gastroenterology & Hepatology

Pan-Caspase Inhibitor VX-166 Reduces Fibrosis in an Animal Model of Nonalcoholic Steatohepatitis

Rafal P. Witek et al.

HEPATOLOGY (2009)

Review Gastroenterology & Hepatology

Current and Future Anti-Fibrotic Therapies for Chronic Liver Disease

Don C. Rockey

CLINICS IN LIVER DISEASE (2008)

Review Gastroenterology & Hepatology

Current status of autologous bone marrow cell infusion therapy for liver cirrhosis patients

Shuji Terai et al.

HEPATOLOGY RESEARCH (2008)

Article Gastroenterology & Hepatology

Antibody-targeted myofibroblast apoptosis reduces fibrosis during sustained liver injury

Angela Douglass et al.

JOURNAL OF HEPATOLOGY (2008)

Article Pharmacology & Pharmacy

Regression of fibrosis after chronic stimulation of cannabinoid CB2 receptor in cirrhotic rats

Javier Munoz-Luque et al.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)

Review Medicine, Research & Experimental

Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ

John P. Iredale

JOURNAL OF CLINICAL INVESTIGATION (2007)

Letter Gastroenterology & Hepatology

A pilot study in patients with established advanced liver fibrosis using pirfenidone

J. Armendariz-Borunda et al.

Article Gastroenterology & Hepatology

Limited therapeutic efficacy of pioglitazone on progression of hepatic fibrosis in rats

I. A. Leclercq et al.

Article Biochemistry & Molecular Biology

Halofuginone induces matrix metalloproteinases in rat hepatic stellate cells via activation of p38 and NFκB

Yury Popov et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2006)

Article Biochemistry & Molecular Biology

CB1 cannabinoid receptor antagonism: a new strategy for the treatment of liver fibrosis

Fatima Teixeira-Clerc et al.

NATURE MEDICINE (2006)

Article Biochemistry & Molecular Biology

Identifying off-target effects and hidden phenotypes of drugs in human cells

Marnie L. MacDonald et al.

NATURE CHEMICAL BIOLOGY (2006)

Article Biochemistry & Molecular Biology

Inhibition of hepatic fibrogenesis by matrix metalloproteinase-9 mutants in mice

Martin Roderfeld et al.

FASEB JOURNAL (2006)

Article Gastroenterology & Hepatology

Attenuated hepatic inflammation and fibrosis in angiotensin type 1a receptor deficient mice

L Yang et al.

JOURNAL OF HEPATOLOGY (2005)

Article Medicine, Research & Experimental

Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair

JS Duffield et al.

JOURNAL OF CLINICAL INVESTIGATION (2005)

Article Gastroenterology & Hepatology

Treatment with human metalloproteinase-8 gene delivery ameliorates experimental rat liver cirrhosis

F Siller-López et al.

GASTROENTEROLOGY (2004)

Article Gastroenterology & Hepatology

Transplantation of bone marrow cells reduces CCl4-induced liver fibrosis in mice

I Sakaida et al.

HEPATOLOGY (2004)